KATHLEEN TONKIN: Open Payments
NPI 1144210402 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 46 payments from 29 companies in 2025. Trend: 2023 $997 · 2024 $1,035 · 2025 $934
Food & beverage: $844Education: $90
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $137 |
| SEAGEN INC. | 1 | $90 |
| ABBVIE INC. | 3 | $74 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Kite Pharma, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Pharmacosmos Therapeutics Inc. | 2 | $34 |
| TerSera Therapeutics LLC | 1 | $32 |
| Iovance Biotherapeutics, Inc. | 1 | $32 |
Products named: IBRANCE, KEYTRUDA, VENCLEXTA, Yescarta, VIVIMUSTA, MONOFERRIC, Zoladex, Amtagvi.
Industry payments across NE — which companies pay providers there.
